USFDA conducts GMP surveillance Inspection at Biocon’s API facility in Visakhapatnam

10 Nov 2025 Evaluate

The U.S. Food and Drug Administration (USFDA) has conducted a GMP surveillance Inspection at Biocon’s API facility (Site 6), located at Visakhapatnam, Andhra Pradesh. The inspection was conducted between November 3 and November 7, 2025. The inspection was concluded with two observations.

Biocon is India’s largest and Asia’s leading Biotechnology Company with a strategic focus on biopharmaceuticals and research services. It is a fully integrated, innovation driven biopharma enterprise offering affordable solutions for chronic diseases to patient's worldwide.

Biocon Share Price

377.80 2.55 (0.68%)
13-Feb-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1698.10
Dr. Reddys Lab 1267.60
Cipla 1330.85
Zydus Lifesciences 904.85
Lupin 2199.20
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×